INS and metabolic dysfunction-associated steatotic liver disease: Since vitamin D effects on NAFLD were tested in T2D patients, we evaluated, as secondary endpoints, the influence of vitamin D treatment on systemic and AT insulin resistance, insulin secretion and glycemic control.